Key Insights

Highlights

No notable highlights available yet

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
P 2 (1)

Trial Status

Recruiting3
Active Not Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT07272811Recruiting

Neurocognitive Assessment Platform 4 Alzheimer

NCT07287527Not ApplicableRecruitingPrimary

Effects of Photobiomodularion on Brain Connectivity and Cognitive Function in Cognitive Impairment

NCT05282550Phase 2RecruitingPrimary

Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone

NCT06755164Not ApplicableActive Not Recruiting

Effects of Combined Aerobic and Cognitive Training in a Simultaneous or Sequential Paradigm on Cognition and Brain Functional Activity in Patients with AMCI

Showing all 4 trials

Research Network

Activity Timeline